Journals of Gerontology Series A: Biological Sciences and Medical Sciences Large Type Edition
 QUICK SEARCH:   [advanced]
Year:  Vol:  Page: 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Cited by other online articles
Google Scholar
Right arrow Articles by Kenny, A. M.
Right arrow Articles by Bellantonio, S.
Right arrow Articles citing this Article
Right arrow PubMed Citation
Right arrow Articles by Kenny, A. M.
Right arrow Articles by Bellantonio, S.
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59:M75-M78 (2004)
© 2004 The Gerontological Society of America


Effects of Testosterone on Behavior, Depression, and Cognitive Function in Older Men With Mild Cognitive Loss

Anne M. Kenny1, Geraldine Fabregas1, Chaewon Song1, Bradley Biskup1 and Sandra Bellantonio1,2

1 Center on Aging, University of Connecticut Health Center, Farmington.
2 Baystate Medical Center, Springfield, Massachusetts.


Background. The role of sex hormones in the prevention of cognitive decline is uncertain. Animal studies suggest mechanisms for sex hormones including testosterone to maintain optimal cognitive function. But, there are studies to suggest that endogenous testosterone levels are associated with aggression in men with cognitive impairment.

Methods. In this pilot study, 11 men (mean age 80 ± 5 years, range 73–87 years) with early cognitive decline and bioavailable testosterone levels below 128 ng/dl (lower limit for adult normal range) were randomized to receive intramuscular testosterone (200 mg every 3 weeks) or placebo for 12 weeks. Outcome measures included sex hormones (testosterone, bioavailable testosterone, sex hormone binding globulin, estradiol, and estrone), Behave AD Questionnaire, Katz Activities of Daily Living, Geriatric Depression Scale, Digit Span, Clock Face Drawing, Clock Face Perception, Verbal Fluency, Trail-Making B, and International Prostate Symptom Score at baseline, 4 weeks, and 10 weeks.

Results. All men completed the study. Total and bioavailable testosterone, estrone, and estradiol levels increased in men receiving testosterone, but no changes were detected in men receiving placebo. No significant changes were found in behavior following testosterone supplementation, nor was there evidence of change in depression or activities of daily living. No discernable changes were found in any of the cognitive tests. Symptoms of prostate hyperplasia remained unchanged in the testosterone (6.6 + 5.8 to 5.2 + 3.6; p =.39) and placebo (8.8 + 6.4 to 6.4 + 3.8; p =.15) groups, and prostate-specific antigen levels did not change significantly.

Conclusion. No significant changes in behavior, function, depression, or cognitive performance occurred following 12 weeks of testosterone replacement in men with low testosterone levels and early-to-moderate cognitive impairment. This pilot work suggests that testosterone can be given to men with early cognitive impairment without significant concern about worsening aggressive or unwanted behaviors.

This article has been cited by other articles: (Search Google Scholar for Other Citing Articles)

Home page
Arch NeurolHome page
P. H. Lu, D. A. Masterman, R. Mulnard, C. Cotman, B. Miller, K. Yaffe, E. Reback, V. Porter, R. Swerdloff, and J. L. Cummings
Effects of Testosterone on Cognition and Mood in Male Patients With Mild Alzheimer Disease and Healthy Elderly Men
Arch Neurol, February 1, 2006; 63(2): 177 - 185.
[Abstract] [Full Text] [PDF]

All GSA journals The Gerontologist
Journals of Gerontology Series B: Psychological Sciences and Social Sciences
Copyright © 2004 by The Gerontological Society of America.